Article Versions Notes

Kawaratani H, Namisaki T, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, Sakamaki A, Hoshikawa K, Uchida Y, Endo K, et al. Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine. 2025; 14(4):1358. https://doi.org/10.3390/jcm14041358

Kawaratani, Hideto, Tadashi Namisaki, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kyoko Hoshikawa, Yoshihito Uchida, Kei Endo, and et al. 2025. "Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study" Journal of Clinical Medicine 14, no. 4: 1358. https://doi.org/10.3390/jcm14041358

Kawaratani, H., Namisaki, T., Kondo, Y., Tatsumi, R., Kawabe, N., Tanabe, N., Sakamaki, A., Hoshikawa, K., Uchida, Y., Endo, K., Kawaguchi, T., Oikawa, T., Ishizu, Y., Hige, S., Takami, T., Terai, S., Ueno, Y., Mochida, S., Koike, K., & Yoshiji, H. (2025). Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine, 14(4), 1358. https://doi.org/10.3390/jcm14041358